Type II

Diabetes could cause up to 12% of US deaths

The proportion of deaths attributable to diabetes in the US is as high as 12 percent—three times higher than estimates based on death certificates suggest—a new analysis shows.

A New Combination Treatment Could Become the Standard T2 Diabetes

A study in Diabetes Care showed that patients with poorly controlled type 2 diabetes who received a combination of exenatide and pioglitazone had a threefold lower rate of hypoglycemia, a one-percentage-point greater reduction in A1C and less weight gain than those in the basal-bolus insulin therapy group.

Research on Remission of Prediabetes to Normal Glucose Tolerance in Obese Adults

This study objective was to determine the effect on remission of prediabetes with a high protein (HP) versus high carbohydrate (HC) diet, and effects on metabolic parameters, and lean and fat body mass in prediabetic, obese subjects after 6 months of dietary intervention. They recruited women and men ages 20–50 years with a BMI ≥ […]

Diabetes Tech ‘Spectations for 2017

We’ve been listening to earnings calls and talking with company execs, industry insiders and PR teams to get a sense of what else is on the horizon, compiled in the following report.

Exercise could improve memory loss in type 2 diabetes

A link between moderate aerobic exercise and improving memory loss in people with diabetes has been found in a new study. Researchers from the University of Tsukaba in Japan found four weeks of moderate activity improved memory dysfunction in mouse models of type 2 diabetes.

Bluetooth insulin dose device helps users keep track of their injections

A new Bluetooth insulin dose tracker, called Insulog, can be fitted onto most existing insulin pens to prevent dose errors in people with type 1 diabetes and insulin-treated type 2 diabetes. The device, created by a Tel Aviv-based startup, is the object of an online crowdfunding campaign recently launched on Indiegogo.

FDA Approves New Diabetes Combo LixiLan and IDegLira for T2 Diabetes

Both products, known as LixiLan and IDegLira during clinical trials, were delayed by 3 months at the U.S. Food and Drug Administration (FDA) following recommendations for approval from FDA panels back in May. And yet the FDA has approved the two new competing combination products containing fixed doses of glucagonlike-peptide 1 (GLP-1) receptor agonists and […]

Long-acting Synjardy gets FDA approval for type 2 diabetes treatment in the US

The US Food and Drug Administration (FDA) has approved the slow release form of Synjardy. Synjardy is a drug used by people with type 2 diabetes in the UK as a twice daily single pill combination therapy to lower blood sugar levels.

Huffpost – Myths About Type 2 Diabetes

More than 29 million people in the U.S., or 9.3 percent of the population, have diabetes, with 1.7 million people ages 20 years or older diagnosed in 2012 alone, according to the Centers for Disease Control and Prevention (CDC).

Eye Is the Focus of World Diabetes Day in 2016

On World Diabetes Day, a consortium of international medical organizations is highlighting the fact that a quarter of people with diabetes are not discussing eye complications with their healthcare professional, despite a worldwide survey indicating that vision loss is feared twice as much as other common complications of diabetes.

Nearly half of adults with type 2 diabetes worldwide are unaware of their condition

A global study by the International Diabetes Federation (IDF) has found that many patients don’t know they have type 2 diabetes, usually due to lack of early screening. Very few people take adequate treatment, with almost one in two (46 per cent) patients still undiagnosed among the estimated 415 million adults living with diabetes across […]

Trial finds type 2 diabetes drug liraglutide can affect heart rate variability

The type 2 diabetes drug liraglutide could affect heart variability in newly diagnosed people who are overweight and have heart problems, according to new research. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist which helps control blood sugar levels and reduces post-meal hyperglycemia. The drug is marketed as Victoza and Saxenda.

diaTribe – Metabolic Surgery Suggested for Some People with Type 2 Diabetes

Diabetes Care, the journal of the American Diabetes Association, published a statement after the 2nd Diabetes Surgery Summit (DSS-II) recognizing metabolic (bariatric) surgery as a standard and safe treatment option for some people with type 2 diabetes.

Junk Food Causes Similar Damage To Kidneys As Type 2 Diabetes

Consuming junk food can cause high blood sugar levels and the same amount of harm to the kidneys as type 2 diabetes, according to a new study published in Experimental Physiology.

Can a Low-Calorie Diet Reverse TII Diabetes?

In this small study of 30 people with type 2 diabetes, researchers found that eight weeks on a very low calorie diet of around 600 to 700 calories a day, followed by a less radical six-month weight control diet, led to significant improvement in blood glucose levels in 12 people.

Metformin is Safe for Over 1 Million More People with Type 2 Diabetes

The FDA recently released a Drug Safety Communication announcing revisions to metformin’s label to expand use in people with type 2 diabetes and mild to moderate kidney (renal) impairment. Previously, the FDA advised against using metformin (Glucophage, Glumetza, Riomet, and Fortamet) in this group.

Study Highlights Risk of Diabetic Ketoacidosis After Bariatric Surgery

People with Type 1 are not immune from obesity, and some turn to bariatric surgery. However, researchers from the Cleveland Clinic found that 25 percent of those with Type 1 who received this surgery suffered from moderate to severe diabetic ketoacidosis (DKA) afterwards.

Wired – TII Diabetes Drug That Also Treats Obesity Could Make Billions

Earlier this month, at the Endocrine Society’s annual conference in Boston, Danish pharma Novo Nordisk presented three years of data showing that their diabetes drug liraglutide helped obese and prediabetic patients lose weight without undue risk. Which is big, for a drug that’s been flagged for causing cancer.

Testosterone Treatment May Help Dieting Men Lose Fat, Fight Diabetes

According to the Department of Medicine at the University of Melbourne in Victoria, Australia, 40 percent of men struggling with obesity have low testosterone. Researchers now believe that adding testosterone treatments to a dieting plan could increase fat reduction.

4 Tips for Diabetic Foot Management

Podiatrists and vascular experts recently developed new diabetic foot management guidelines, according to a Medscape report. Recommendations focus on preventing and relieving major foot issues that can come with diabetes. Here are some highlights of what they recommended.